Drug profile · INN
lurbinectedin
ZEPZELCA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lurbinectedin (ZEPZELCA) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN lurbinectedin
Brand ZEPZELCA
Route INTRAVENOUS
Formulation POWDER
ATC code L01XX69
Originator Jazz Pharmaceuticals Ireland Limited
Frequently asked questions
What is lurbinectedin?
lurbinectedin (ZEPZELCA) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for lurbinectedin?
ZEPZELCA is a marketed brand name for lurbinectedin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lurbinectedin?
lurbinectedin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.